Barclays initiated coverage of Elevance Health with an Overweight rating and $584 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ELV:
- Elevance Health Projects Strong 2024 Earnings and Star Rating Boost
- Elevance Health Declares Quarterly Dividend for Shareholders
- Elevance Health (NYSE:ELV) Jumps after Exceeding Q4 Estimates
- Elevance Health reports Medical membership totaled ~47M at Dec. 31, 2023
- Elevance Health raises quarterly dividend 10.1% to $1.63 per share
Questions or Comments about the article? Write to editor@tipranks.com